| COMMENTARY |
|
| Year : 2018 | Volume
: 9
| Issue : 1 | Page : 27 |
|
|
Will digital pathology be as disruptive as genomics?
Steven N Hart
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA
Correspondence Address:
Dr. Steven N Hart
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jpi.jpi_25_18
|
|
|
Digital pathology is the science of performing traditional pathological assessment in a digital environment. A digital transition is long overdue since histochemical analysis such as hematoxylin and eosin staining has remained unchanged in over 100 years. Importantly, the digitization of whole slide images further lends itself to advances in computational pathology and artificial intelligence to transform qualitative assessment into quantitative assessment. The impact of this transition from a computational infrastructure perspective is reminiscent of a similar transition in the field of genomics. In this article, I describe some of the similarities between genomics and digital pathology as well as highlight some key lessons learned to prevent the same mistakes and delays that slowed the genomics revolution.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
